mAFA intervention
thromboembolic, hypertension, bleeding
VASCULAR DISEASES, BLEEDING, HYPERTENSION, HEART
The mAFA intervention group implemented the ABC pathway according to the following criteria:‘A’ criterion: anticoagulation prescription according to regular assessment of thromboembolic and bleeding risk, with dose adjustment based on renal and liver function reassessment;‘B’ criterion: regular monitoring of patient-reported symptoms (which were assessed according to the European Heart Rhythm Association classification), and management of symptoms that included antiarrhythmics and rhythm control treatments;‘C’ criterion: active management and treatment optimization of concurrent comorbidities (e.g., hypertension management according to blood pressure monitoring, statin treatment in patients with vascular diseases, etc.). Patients were also provided with educational material and lifestyle recommendations.Conversely, patients allocated to “usual care” were managed according to local practices.